Arlington seeks public input on the "Innovate Arlington" Comprehensive Plan through an online survey and workshops.

Arlington announces the INDYCAR Grand Prix of Arlington debuting March 2026 with a 2.73-mile street circuit race.

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing ...

The Arlington bowling team last fall was sure its season would end triumphantly, and they made it come to fruition, winning ...

From excitement to calls for a referendum — with a measure of caution in between — views vary among the Arlington Heights ...

The race will wind through the streets of Arlington’s sports and entertainment district when the engines start in March 2026.

The same investment firm that is selling BlueHalo to AeroVironment is now ready to showcase GRVTY, a specialist in geospatial ...

Bethesda PE firm Arlington Capital Partners has launched a new defense tech firm and tapped a former COO at two of its portfolio companies to run it.

Just over a year after Flight Wine Bar closed its doors, owners Swati Bose and Kabir Amir have opened a bottle shop, under ...

The IndyCar Arlington Grand Prix will be held March 13-15, 2026 – mere months before the 2026 FIFA World Cup comes to the area in June and July.

(RTTNews) - Viridian Therapeutics (VRDN) Monday has granted 113,200 stock options to nine new employees and 310,700 stock options to newly appointed Chief Medical Officer, Dr. Radhika Tripuraneni.